Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

WHY IT MATTERS: Patients in Brazil and those watching international cannabis policy should know that new domestic cultivation rules could meaningfully expand access to locally produced, regulated cannabis medicines, potentially lowering costs and improving product consistency. CLINICAL OVERVIEW: Brazil’s updated cannabis regulatory framework represents a significant shift toward integrating medical cannabis into the formal healthcare system, including provisions for domestic cultivation under health authority oversight. The framework addresses THC-containing products more explicitly, which has direct implications for how physicians can recommend and patients can access a broader range of cannabinoid formulations.

Read More

The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com

WHY IT MATTERS: Alabama patients with qualifying conditions will soon have legal, regulated access to medical cannabis through licensed dispensaries, potentially replacing unsafe or illegal sources they may have been relying on. CLINICAL OVERVIEW: Alabama is preparing to launch its long-delayed medical cannabis program, marking a significant shift for a state that has historically maintained some of the strictest drug policies in the country. The program will allow qualifying patients with conditions such as chronic pain, PTSD, anxiety, and terminal illness to access cannabis through licensed dispensaries under physician supervision.

Read More

West Virginia House approves bill allowing medical cannabis edibles | WV News

WHY IT MATTERS: West Virginia medical cannabis patients who previously had limited delivery options may soon be able to access edible formulations, giving physicians and patients more tools to tailor treatment to individual medical needs. CLINICAL OVERVIEW: West Virginia’s expansion of its medical cannabis program to include edible formulations represents a meaningful step toward improving patient access and treatment flexibility. Edibles offer distinct pharmacokinetic advantages for certain patient populations, particularly those with respiratory conditions who cannot tolerate inhalation, or those requiring longer-duration symptom relief due to the slower onset and extended duration of orally administered cannabinoids.

Read More

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

WHY IT MATTERS: Patients with debilitating conditions who struggle to travel to dispensaries may soon have more reliable, regulated delivery options that make consistent access to their recommended cannabis products genuinely feasible. CLINICAL OVERVIEW: Medical cannabis delivery services represent a meaningful evolution in how patients access their medicine, particularly for those with mobility limitations, chronic illness, or conditions that make visiting a dispensary physically difficult. As regulatory frameworks in various jurisdictions begin to accommodate telehealth consultations and home delivery, the logistical gap between a physician’s recommendation and a patient actually receiving their medicine is narrowing.

Read More

Proposed Nebraska Medical Marijuana Emergency Rules Spark Concern (THC Limits, Rural Access)

WHY IT MATTERS: If Nebraska finalizes these emergency rules as written, patients with legitimate medical needs may find themselves rationed to doses too low to provide meaningful relief, with no practical path to adjust their treatment for 90 days at a time. CLINICAL OVERVIEW: Nebraska’s proposed emergency medical cannabis rules include a 5-gram THC dispensing limit every 90 days and a 40-milligram per-dose cap, both of which reflect a fundamental misunderstanding of how cannabis medicine works in clinical contexts. These restrictions could leave patients with serious conditions severely undertreated, particularly those managing chronic pain, cancer-related symptoms, or neurological disorders who often require individualized dosing that far exceeds arbitrary bureaucratic thresholds.

Read More

Extended moratorium on Oklahoma medical marijuana business licenses approved by House

WHY IT MATTERS: Oklahoma medical cannabis patients may see shifts in dispensary availability and product selection as licensing freezes and cultivation limits reshape which businesses can survive in an already competitive market. CLINICAL OVERVIEW: Oklahoma has been one of the most permissive states for medical cannabis licensing, resulting in a densely saturated market that has created significant regulatory and quality control challenges. Legislative efforts to extend moratoriums on new business licenses and cap cultivation operations reflect an attempt to bring structure to an industry that expanded faster than oversight mechanisms could follow.

Read More

Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE

WHY IT MATTERS: If Kansas passes medical cannabis legislation, patients currently traveling to neighboring states or going without treatment may soon be able to access cannabis-based therapies legally and closer to home. CLINICAL OVERVIEW: Kansas is considering legislation that would establish both medical and recreational cannabis frameworks, representing a significant shift for one of the few remaining states with no legal cannabis access. The medical proposals include pathways for patients with qualifying conditions to access cannabis-based treatments under physician supervision, while rescheduling efforts at the federal level have created new momentum for states like Kansas to act.

Read More

Legislation on medical cannabis: DOH bares conditions – Cebu Daily News

WHY IT MATTERS: Filipino patients with conditions like chronic pain, epilepsy, or cancer-related symptoms may soon have a clearer legal pathway to access medical cannabis, but only if proposed legislation meets the scientific standards regulators are demanding. CLINICAL OVERVIEW: Medical cannabis legislation in the Philippines is advancing through regulatory channels, with health authorities emphasizing that any framework for legal access must be grounded in robust clinical and scientific evidence. This position reflects a cautious but scientifically oriented approach to policy, requiring that efficacy and safety data drive decisions rather than anecdotal reports or political pressure.

Read More

House panel approves proposed medical cannabis law – POLITIKO

WHY IT MATTERS: If this medical cannabis law passes in the Philippines, patients with qualifying conditions may gain legal access to cannabis-based treatments that were previously unavailable or carried serious legal risk. CLINICAL OVERVIEW: The Philippine House of Representatives has moved forward with proposed legislation that would formalize a medical cannabis framework, focusing on expanding research infrastructure and creating regulated pathways for patient access. This represents a significant shift in drug policy for a country that has historically maintained strict prohibitionist stances toward cannabis.

Read More